Obesity: Drugs
Commons · Question 73954 · Tabled 1 Sep 2025 · Department of Health and Social Care · Official record
Answered 19 Sep 2025
Question
Asked by Jess Brown-Fuller
To ask the Secretary of State for Health and Social Care, what steps he is taking to expand access to weight loss medications through the NHS.
Answer
Answered by Zubir Ahmed, 19 Sep 2025
Until recently, the newest obesity medicines liraglutide, under various brand names, semaglutide, under the brand name Wegovy, and tirzepatide, under the brand name Mounjaro, have only been available via the National Health Service through specialist weig...